Compare FIP & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIP | MRVI |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.1M | 559.0M |
| IPO Year | 2021 | 2020 |
| Metric | FIP | MRVI |
|---|---|---|
| Price | $4.85 | $5.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $11.00 | $4.13 |
| AVG Volume (30 Days) | 831.7K | ★ 2.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ 16.91 | 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,520,000.00 | $185,743,000.00 |
| Revenue This Year | $58.19 | $12.54 |
| Revenue Next Year | $30.58 | $7.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.59 | N/A |
| 52 Week Low | $3.90 | $1.99 |
| 52 Week High | $7.93 | $5.30 |
| Indicator | FIP | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 53.34 | 67.64 |
| Support Level | $4.56 | $3.27 |
| Resistance Level | $6.23 | N/A |
| Average True Range (ATR) | 0.30 | 0.25 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 74.75 | 78.29 |
FTAI Infrastructure Inc is engaged in five segments; Railroad segment, which includes eight freight railroads and one switching company that provide rail service to certain manufacturing and production facilities; the Jefferson Terminal segment, which consists of a multi-modal crude oil and refined products terminal and other related assets; The Repauno segment, which consists of a deep-water port located along the Delaware River with an underground storage cavern, a multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities; Power and Gas segment, which comprised Long Ridge, a multi-modal terminal located along the Ohio River; and Sustainability and Energy Transition segment, which comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.